ITGAM and neoplasm: These conflicting results could stem from the heterogeneity of CD11b+ myeloid cells because CD11b expression is observed in various inflammatory cells, including tumor-infiltrating monocytes, TAMs, granulocytes, and dendritic cells, and rarely, T-cells, B-cells, and NK and NK-T cells [37].